Skin Glycans and Aging: How Sugars Shape Skin Health, Collagen and Visible Aging

Glycans (complex sugars) coat every cell in the human body, including every cell in your skin, and regulate the molecular processes that determine how skin ages. These sugars are not passive structural components. They give proteins their functional shape and govern how cells communicate with one another. Without glycans, the proteins that maintain skin architecture, including collagen, cannot function correctly.

Glycosylation (the biological process by which cells manufacture and attach these complex sugars to proteins) is a sophisticated, genetically regulated mechanism that evolved to control molecular function in real time. It is entirely distinct from glycation, the random, diet-driven damage to proteins caused by glucose spikes, which is a loss-of-function process rather than a regulated one. When clinicians or researchers discuss skin glycans and aging, they are referring to glycosylation, not glycation.

New to glycan science? Start with the foundational guide: Glycans: The Sugars That Reveal Your Biological Age and Immune Health — then return here for the skin-specific evidence.

How does glycosylation affect collagen and skin structure?

Glycosylation directly determines whether structural proteins like collagen function as they should. Glycans attached to collagen molecules regulate how collagen fibers assemble, how they interact with surrounding cells, and how efficiently they are turned over by surrounding cells. Without the correct glycan coating, these proteins lose function, not because the protein itself is damaged, but because the molecular instruction layer that governs its behavior has changed.

This is why glycan biology operates at a level upstream of the visible signs of aging: changes in glycosylation patterns precede the loss of skin firmness and elasticity that eventually becomes apparent on the surface. GlycanAge does not measure skin or collagen glycosylation directly; it measures the glycans on IgG antibodies that govern the systemic inflammatory environment. This is the same environment that drives collagen degradation and determines the pace of visible skin aging.

Is glycosylation the same as glycation?

People confuse these terms constantly. Glycosylation and glycation are fundamentally different processes, and conflating them leads to significant misunderstanding of skin aging biology. Glycosylation is a regulated, evolutionarily developed biological process in which cells manufacture complex sugars and attach them precisely to proteins and lipids to confer function.

Glycation is the opposite: an unregulated, random process in which dietary glucose damages proteins (the mechanism behind the skin-stiffening effects of a high-sugar diet). GlycanAge measures glycosylation patterns on Immunoglobulin G (IgG) antibodies, not glycation damage. The two processes have different drivers, different consequences, and require different measurement approaches.

What is the connection between chronic inflammation, glycans, and visible skin aging?

Chronic, low-grade inflammation, now recognized as a primary hallmark of aging and referred to in the scientific literature as inflammaging, accelerates biological aging across every tissue, including skin. Inflammaging is not the acute redness of a wound or infection; it is a persistent, sterile inflammatory state driven by senescent cells, oxidative stress, and other internal processes.

Glycans on IgG antibodies are direct regulators of this inflammatory state: shifts in their composition tip the immune system toward pro-inflammatory or anti-inflammatory activity. As the ratio of pro-inflammatory to anti-inflammatory glycans increases with age, the chronic inflammatory environment that degrades skin structure intensifies, making IgG glycosylation one of the most precise available measures of the biological process driving skin aging from the inside.

How does GlycanAge measure the inflammatory biology relevant to skin aging?

GlycanAge analyses 29 glycan structures attached to IgG antibodies from a finger-prick blood sample, calculating the ratio of pro-inflammatory to anti-inflammatory glycans to produce a biological age score. This score reflects the current state of immune aging and chronic inflammation — not genetic potential and not a historical snapshot of gene expression.

"The most valuable thing about glycans is that they can be easily and reliably quantified. We get a drop of blood, ship it to the lab, and return a glycome composition which can be distilled into a number that estimates biological age."

— Prof. Gordan Lauc, Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb

For skin health specifically, this matters because the inflammatory biology GlycanAge captures is the same biology that governs collagen degradation, cellular repair capacity, and the pace of visible skin aging.

Can lifestyle or aesthetic interventions actually change glycan patterns and how quickly?

Glycan patterns respond measurably to lifestyle and medical interventions, typically within three to six months of a targeted change. Research into the effects of different dietary approaches found that in overweight individuals, caloric restriction resulting in weight loss produced measurable anti-inflammatory changes in IgG glycosylation, specifically a decrease in the pro-inflammatory Glycan Mature index and an increase in the anti-inflammatory Glycan Shield index. These changes returned toward baseline when weight was subsequently regained, underscoring that sustained lifestyle change, not short-term restriction alone, drives lasting glycan improvement.

"If I change to a healthier lifestyle, it actually goes down. In a difficult period, it can accelerate — in a year I could lose ten years of my GlycanAge."

— Prof. Gordan Lauc, Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb

This responsiveness is what makes glycan measurement actionable for aesthetic and longevity clinics: rather than waiting for visible skin changes to confirm whether an intervention is working, practitioners can measure the underlying inflammatory biology that drives those changes months earlier.

Why can't a standard blood panel or skin assessment tell me the same thing?

Acute inflammatory markers, including CRP, IL-6, and TNF-alpha, as well as ratios derived from standard blood tests such as the neutrophil-to-lymphocyte ratio, fluctuate with acute infection and daily variation, making them poor measures of the chronic, sterile inflammation that drives skin aging. They capture a snapshot of acute immune activity, not the sustained inflammatory state that accumulates over years and degrades skin structure. Glycans, by contrast, integrate genetic, epigenetic, and environmental factors into a single stable signal that sits between the rapid fluctuation of metabolites and the fixed nature of genes.

"We are missing some kind of intermediate phenotype between day-to-day altering molecules and genes which do not change — and these are the glycans."

— Prof. Gordan Lauc, Chief Scientific Officer, GlycanAge; Professor of Biochemistry and Molecular Biology, University of Zagreb

For aesthetic clinicians, this means glycan measurement provides a layer of biological insight that no standard panel currently captures.

Should aesthetic clinics use GlycanAge as part of their patient assessment workflow?

GlycanAge functions as an objective, validated biomarker for tracking whether interventions are producing measurable biological change, making it a practical tool for any clinic that wants to demonstrate the systemic impact of its protocols. Many practitioners use it to baseline patients before initiating a programme, then retest at three to six months to confirm biological response. The measurement is not a diagnostic tool; it is a biomarker of immune aging and chronic inflammation, designed to be interpreted alongside clinical history and other health data.

For aesthetic clinics expanding into longevity and preventive health, GlycanAge provides the objective measurement layer that connects visible skin outcomes to the underlying biology, and gives patients a concrete, motivating signal that their investment in their health is working at a molecular level.

What does it mean if my biological age is higher than my chronological age and what should I do?

A GlycanAge result higher than your chronological age indicates that your immune system is aging faster than expected for someone of your years, driven by a pro-inflammatory glycan profile. This is not a diagnosis of any specific condition; it is a signal that the chronic inflammatory biology associated with accelerated aging, and with the skin, cardiovascular, and metabolic consequences that follow, is more active than it should be.

The actionable response is to identify the modifiable drivers: diet, sleep quality, stress load, exercise pattern, hormonal status, and body composition are all factors that influence glycan composition and respond to targeted change. Retesting after three to six months of a structured intervention gives you an objective measure of whether the biology has shifted, not just whether you feel better or look different, but whether the molecular markers of aging have moved in the right direction.

If you want to understand the inflammatory biology driving your skin's aging, and measure whether your interventions are actually working at a molecular level, a GlycanAge test gives you that answer from a single finger-prick blood sample. Every test includes a 1:1 Result Interpretation Call with a longevity specialist who will walk you through your biological age, your glycan profile, and a personalized plan for what to address first.

Order your GlycanAge test kit → Shop Now

Aesthetic and longevity clinics looking to integrate glycan biomarker testing into their patient workflow can explore the GlycanAge Healthcare Providers programme for clinical onboarding, volume pricing, and practitioner support.

External Sources

• https://www.cell.com/cell/fulltext/S0092-8674(22)01377-0 — López-Otín C, Blasco MA, Partridge L, Serrano M, Kroemer G. Hallmarks of aging: An expanding universe. Cell. 2023;186(2):243–278.

• https://pubmed.ncbi.nlm.nih.gov/24325898/ — Krištić J, Vučković F, Menni C, et al. Glycans are a novel biomarker of chronological and biological ages. J Gerontol A Biol Sci Med Sci. 2014;69(7):779–789.

• https://www.ncbi.nlm.nih.gov/books/NBK579930/ — Essentials of Glycobiology, 4th edition. Chapter: Glycans in Acquired Human Diseases. NCBI Bookshelf NBK579930.